Labcorp Holdings Inc., a global leader in laboratory services, will announce its financial results for the third quarter of 2026 on October 28 before the market opens. The company will host a webcast at 9:00 a.m. ET to discuss the results, accessible via its investor relations website. Labcorp's extensive operations include supporting drug approvals and performing hundreds of millions of tests worldwide, making this earnings report significant for investors tracking healthcare and diagnostics sectors.
Labcorp Holdings Inc. is set to announce its third quarter 2026 financial results on October 28. For readers following the health sector, here is Pluang's market snapshot as of September 30, 2026, 19:11 WIB: out of 100 priced health-sector US stocks, 45 rose and 50 fell. Notable movers include RXRX at USD 3.98 with a typical hold time of 23 days and 100% buy order activity, BDX at USD 184.18 with a typical hold time of 102 days and 100% sell order activity, and FLNA at USD 0.92 with a typical hold time of 37 days and 73% buy order activity.
CareCloud has named Mitchell Brie as Chief Compliance Officer to lead its growing healthcare compliance business. Brie, founder of Empower Healthcare & Compliance Partners (acquired by CareCloud), will oversee corporate compliance and continue as Pre...
eSoftware Associates advises defense contractors to carefully map controlled unclassified information (CUI) access permissions before licensing Microsoft 365 Copilot in the GCC High cloud environment. Moving to GCC High does not automatically grant c...
Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...
Nautilus Biotechnology announced its Q3 2026 financial results, reporting $0.2 million in revenue mainly from grants and early access services, and a net loss of $15.6 million. The company highlighted progress in its proteome analysis platform, inclu...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a tactical decision-support solution designed to aid naval officers in complex maritime environments. The system uses operational data and AI to enhance situational awareness, reduce cognitive loa...
